Israel - English - Ministry of Health

novartis israel ltd - baclofen - tablets - baclofen 25 mg - other centrally acting agents - muscle spasticity of various origins.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - baclofen, quantity: 25 mg - tablet, uncoated - excipient ingredients: wheat starch; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; povidone - suppression of voluntary muscle spasm in: *multiple sclerosis, *spinal lesions of traumatic, infectious, degenerative, neoplastic and unknown origin, causing: - skeletal hypertonus - spastic and dyssynergic bladder dysfunction. not recommended in parkinson's disease or spasticity arising from strokes, cerebral palsy or rheumatoid disorders

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - baclofen, quantity: 25 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; wheat starch; microcrystalline cellulose; magnesium stearate; povidone - suppression of voluntary muscle spasm in: *multiple sclerosis, *spinal lesions of traumatic, infectious, degenerative, neoplastic and unknown origin, causing: - skeletal hypertonus - spastic and dyssynergic bladder dysfunction. not recommended in parkinson's disease or spasticity arising from strokes, cerebral palsy or rheumatoid disorders

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - baclofen, quantity: 10 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; wheat starch - suppression of voluntary muscle spasm in: *multiple sclerosis, *spinal lesions of traumatic, infectious, degenerative, neoplastic and unknown origin, causing: - skeletal hypertonus - spastic and dyssynergic bladder dysfunction. not recommended in parkinson's disease or spasticity arising from strokes, cerebral palsy or rheumatoid disorders

Israel - English - Ministry of Health

novartis israel ltd - baclofen - tablets - baclofen 10 mg - baclofen - baclofen - muscle spasticity of various origins.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

novartis south africa (pty) ltd - tablet - see ingredients - each tablet contains baclofen 10 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

novartis south africa (pty) ltd - tablet - see ingredients - each tablet contains baclofen 25 mg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c spain - 50's (10's blister x 5) - tablet - 25mg / tablet - musculoskeletal ,joint diseases-neuromuscular disorders

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - baclofen 25 mg - tablet - 25 mg - baclofen 25 mg - baclofen

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis, switzerland - baclofen - tablet - 25 mg